You are using an older browser version. Please use a supported version for the best MSN experience.

Pfizer begins trial of Omicron specific jab

Pfizer has started clinical trials on a Omicron tailored version of its COVID vaccine. US health officials believe the variant will be the dominant strain in the community for some time and a targeted vaccine will be beneficial as a booster.
image beaconimage beaconimage beacon